MedTrace Logo

Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients

NCT01401972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2019-09-23

No results posted yet for this study

Summary

In this observational study the investigators will undertake imaging studies on men with prostate cancer. The primary hypothesis is that ultrasound spectroscopy could be used to determine the extent of disease inside and outside of the prostate gland in patients with prostate cancer. It is hoped that the changes in ultrasound backscatter parameters obtained before radical prostatectomy could be used to correlate with pathological findings from the prostate specimen after surgery.

Conditions

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Gregory Czarnota, PhD, M.D. · Sunnybrook Health Sciences Centre

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01401972 on ClinicalTrials.gov